Skip Navigation
Skip to contents

SIDDS 2022

SIDDS 2022

Invited Speakers

PG Course (Liver)
Current and future management of nonalcoholic fatty liver disease

  • Seung Up Kim Noninvasive methods to stratify the risk of disease progression in nonalcoholic fatty liver disease Seung Up Kim Yonsei University, Korea CV
  • Vincent Wai-Sun Wong Clinical impact of metabolic associated fatty liver disease Vincent Wong The Chinese University of Hong Kong, China CV
  • Byoung Kuk Jang Emerging drugs for nonalcoholic steatohepatitis Byoung Kuk Jang Keimyung University, Korea CV
  • Young Suk Park Role of bariatric surgery in the treatment of nonalcoholic fatty liver disease Young Suk Park Seoul National University, Korea CV

PG Course (PB)
Biliary disease: What’s new in 2022?

  • Sung Ill Jang Gallbladder stone and polyp Sung Ill Jang Yonsei University, Korea CV
  • Dong Uk Kim Premalignant lesion in biliary tract Dong Uk Kim Pusan National University, Korea CV
  • Palak J. Trivedi Primary sclerosing cholangitis Palak J. Trivedi University of Birmingham, UK CV
  • Byoung Kuk Jang IgG4 related sclerosing cholangitis Seung Bae Yoon The Catholic University, Korea CV

PG Course (UGI)
Current perspectives of gastric cancer

  • Sun Young Lee Helicobacter pylori and gastric cancer Sun-Young Lee Konkuk University, Korea CV
  • Jae Myung Park Improving early detection of gastric cancer Jae Myung Park The Catholic University, Korea CV
  • Hwoon-Yong Jung Endoscopic resection of gastric cancer Hwoon-Yong Jung University of Ulsan, Korea CV
  • Satoki Shichijo Endoscopic features and risk factors of gastric cancer after Helicobacter pylori eradication Satoki Shichijo Osaka International Cancer Institution, Japan CV

PG Course (LGI)
The cutting edge of serrated polyps

  • Serrated pathway in colorectal carcinogenesis Baek-hui Kim Korea University, Korea CV
  • Jun Lee Detection and characterization of serrated polyps Jun Lee Chosun University, Korea CV
  • Endoscopic resection of serrated lesions in the colon Shai Friedland Stanford University, USA CV
  • Dong Hoon Baek Serrated polyposis syndrome: A to Z Dong Hoon Baek Pusan National University, Korea CV

Symposium 1 (UGI)
Helicobacter pylori management in 2022

  • Il Ju Choi Must-know evidence for gastric cancer prevention Il Ju Choi National Cancer Center, Korea CV
  • Tae Jun Kim Benefits of H. pylori eradication beyond gastric cancer prevention Tae Jun Kim Sungkyunkwan University, Korea CV
  • Jun-Won Chung H. pylori eradication therapy in East Asia: Empirical vs. Tailored Jun-Won Chung Gachon University, Korea CV
  • P-CAB-based H. pylori eradication therapy: A real-world evidence Takahisa Furuta Hamamatsu University, Japan CV

Symposium 2 (LGI)
Precision medicine in IBD: Current status and future perspective

  • Kyunggon Kim Application of proteomics in biomarker discovery of IBD Kyunggon Kim University of Ulsan, Korea CV
  • Pharmacogenetic approaches in IBD: Applying in clinical practice Katsuyoshi Matsuoka Toho University Sakura Medical Center, Japan CV
  • Jaeyoung Chun Application of artificial intelligence-based systems in IBD Jaeyoung Chun Yonsei University, Korea CV
  • Jung Kyoon Choi Single-cell multiomics approach to understanding IBD and colon cancer Jung Kyoon Choi KAIST, Korea CV

Symposium 3 (Liver)
Evolving treatment of hepatocellular carcinoma

  • Min Woo Lee Methods to improve the efficacy of local ablation therapy Min Woo Lee Sungkyunkwan University, Korea CV
  • Hae Won Lee Expanded criteria for surgical resection and liver transplantation Hae Won Lee Seoul National University, Korea CV
  • Toshihiro Tanaka Current status of transarterial therapy Toshihiro Tanaka Nara Medical University, Japan CV
  • Bo Hyun Kim New and emerging systemic treatments Bo Hyun Kim National Cancer Center, Korea CV

Symposium 4 (Big Data)
Decoding complexity: Big data research in gastroenterology

  • Cheol Min Shin Obesity and metabolic syndrome in upper gastrointestinal tract cancers Cheol Min Shin Seoul National University, Korea CV
  • Jung Yong Hong Metabolic syndrome and the risk of pancreas cancer Jung Yong Hong Sungkyunkwan University, Korea CV
  • Yun Bin Lee Metabolic syndrome and the risk of hepatocelluar carcinoma Yun Bin Lee Seoul National University, Korea CV
  • Wang Yen-po Inflammatory bowel disease and dementia Wang Yen-po Taipei Veterans General Hospital, Taiwan CV

Symposium 5 (Motility)
Current management for functional gastrointestinal disorders: Promises, limitations, and insights for future directions

  • Young Hoon Youn The POEM procedure for achalasia Young Hoon Youn Yonsei University, Korea CV
  • Tadayuki Oshima The spectrum of GERD: A new perspective Tadayuki Oshima Hyogo College of Medicine, Japan CV
  • Jung Ho Park What you should know about managing irritable bowel syndrome Jung Ho Park Sungkyunkwan University, Korea CV
  • Uday C Ghoshal Microbial-based functional gastrointestinal disorder therapy Uday C Ghoshal Sanjay Gandhi Postgraduate Institute of Medical Sciences, India CV

Symposium 6 (PB)
Practical guide to the diagnosis and management of chronic pancreatitis

  • Jong Jin Hyun Etiology, epidemiology and diagnostic criteria for chronic pancreatitis Jong Jin Hyun Korea University, Korea CV
  • Sundeep Lakhtakia Endoscopic treatment of chronic pancreatitis and its complications Sundeep Lakhtakia AIG Hospitals, India CV
  • Joon Seong Park Surgery for chronic pancreatitis and its complications Joon Seong Park Yonsei University, Korea CV
  • Joo Kyung Park Conservative management and follow up strategy of chronic pancreatitis Joo Kyung Park Sungkyunkwan University, Korea CV

Symposium 7 (Gender)
Gender issues in GI cancers: Impact on epidemiology, pathogenesis, and treatment

  • Hidekazu Suzuki Gastric cancer Hidekazu Suzuki Tokai University, Japan CV
  • Hyun Joo Song Colorectal cancer Hyun Joo Song Jeju National University, Korea CV
  • Hye Won Lee Liver cancer Hye Won Lee Yonsei University, Korea CV
  • Seon Mee Park Pancreato-biliary cancer Seon Mee Park Chungbuk National University, Korea CV

Symposium 8 (Oncology)
Perspectives on management of advanced/metastatic GI cancer: Chemotherapy, immunotherapy and novel drugs

  • Eun Sun Kim Colorectal cancer Eun Sun Kim Korea University, Korea CV
  • Hee Seung Lee Pancreatic cancer Hee Seung Lee Yonsei University, Korea CV
  • Michelle Kang Kim Gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) Michelle Kang Kim Mount Sinai Health System, USA CV
  • Tae Ho Kim Gastrointestinal stromal tumor (GIST) Tae Ho Kim The Catholic University, Korea CV

Symposium 9 (Basic Research)
Noncoding RNA: A key player in gastrointestinal disease

  • Young-Sun Lee MicroRNA as novel biomarker for disease severity evaluation and therapeutic target in NAFLD Young-Sun Lee Korea University, Korea CV
  • Jin Wu Nam Long non-coding RNAs within the tumor microenvironment and their role in tumour-stroma cross-talk Jin Wu Nam Hanyang University, Korea CV
  • Ekihiro Seki MicroRNA regulation of liver fibrosis and alcoholic liver disease Ekihiro Seki Cedars-Sinai Medical Center, USA CV
  • Hyeon Ho Kim Circular RNA as a key player in colon cancer metastasis Hyeon Ho Kim Sungkyunkwan University, Korea CV

상단으로 이동

Copyright© The Korean Society of Gastroenterology. All Rights Reserved.

Room 305, 31 Seolleung-ro 86 Gil, Gangnam-gu, Seoul, 06193, Korea
SIDDS 2022 Secretariat
30, Bamgogae-ro 1-gil, Gangnam-gu, Seoul, Korea